Use of Glucagon-like peptide 2 (GLP-2) analogs in inflammatory bowel disease

Use of Glucagon-like peptide 2 (GLP-2) analogs in inflammatory bowel disease

Introduction: Inflammatory bowel disease (IBD) is a chronic condition that involves long-term treatment and chronic idiopathic inflammation within the gastrointestinal tract. The predominant forms of IBD are: Crohn's disease and ulcerative colitis. These diseases cause significant physical a...

Full description

Bibliographic Details
Main Authors: Dobromiła Osuch, Piotr Zatyka, Adam Słomczyński, Agata Pawłowska, Michal Rabenda, Piotr Janik, Dominika Opala
Format: Article
Language:English
Published: Nicolaus Copernicus University in Toruń 2024-08-01
Series:Quality in Sport
Subjects:
GLP-2
inflammatory bowel disease
Crohn's disease
ulcerative colitis
short bowel syndrome
Online Access:https://apcz.umk.pl/QS/article/view/53227

Internet

https://apcz.umk.pl/QS/article/view/53227

Similar Items